
    
      Participant will follow either a prophylaxis or on-demand regimen. The starting dose in this
      study will be determined by the clinical profile of the participant in the preceding studies
      A-LONG - 997HA301 (NCT01181128), pediatric study 8HA02PED (NCT01458106), 997HA307
      (NCT02083965) and 997HA309 (NCT02502149).
    
  